The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
Open accessAbstract
Muscarinic M1–M5 acetylcholine receptors are G-protein-coupled receptors that regulate many vital functions of the central and peripheral nervous systems. In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurological disorders, such as Alzheimer’s disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors. Here we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium. Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family. We also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Electrostatics of nanosystems: Application to microtubules and the ribosome
Baker, N. A., Sept, D., Joseph, S., Holst, M. J., & McCammon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181342398 · Cited by 7,172
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 6,988
PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations
Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., & Baker, N. A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh381 · Cited by 3,472
Guex, N., Peitsch, M. C., & Schwede, T. (2009) · ELECTROPHORESIS · doi:10.1002/elps.200900140 · Cited by 2,097
Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., & Baker, N. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm276 · Cited by 2,001
Motulsky, H. J., & Christopoulos, A. (2004) · Cited by 1,972
Self-citationSwissDock, a protein-small molecule docking web service based on EADock DSS
Grosdidier, A., Zoete, V., & Michielin, O. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr366 · Cited by 1,950
Ashkenazy, H., Erez, E., Martz, E., Pupko, T., & Ben-Tal, N. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq399 · Cited by 1,848
Linking Crystallographic Model and Data Quality
Karplus, P. A., & Diederichs, K. (2012) · Science · doi:10.1126/science.1218231 · Cited by 1,781
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures
Landau, M., Mayrose, I., Rosenberg, Y., Glaser, F., Martz, E., Pupko, T., & Ben-Tal, N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki370 · Cited by 1,413
Motulsky, H., & Christopoulos, A. (2004) · doi:10.1093/oso/9780195171792.001.0001 · Cited by 1,392
Self-citationEvolutionarily Conserved Pathways of Energetic Connectivity in Protein Families
Lockless, S. W., & Ranganathan, R. (1999) · Science · doi:10.1126/science.286.5438.295 · Cited by 1,303
Glaser, F., Pupko, T., Paz, I., Bell, R. E., Bechor-Shental, D., Martz, E., & Ben-Tal, N. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.163 · Cited by 1,236
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citationStructure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Self-citationStructure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792
Self-citationBodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 692
Crystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
ConSurf: Using Evolutionary Data to Raise Testable Hypotheses about Protein Function
Celniker, G., Nimrod, G., Ashkenazy, H., Glaser, F., Martz, E., Mayrose, I., Pupko, T., & Ben‐Tal, N. (2013) · Israel Journal of Chemistry · doi:10.1002/ijch.201200096 · Cited by 560
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.06091591 · Cited by 560
Self-citationFusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Muscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Self-citationEhlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Modification of the binding properties of muscarinic receptors by gallamine.
Stockton, J. M., Birdsall, N. J., Burgen, A. S., & Hulme, E. C. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14327-7 · Cited by 328
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
Conn, P. J., Jones, C. K., & Lindsley, C. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.002 · Cited by 286
Ma, L., Seager, M. A., Wittmann, M., Jacobson, M., Bickel, D., Burno, M., Jones, K., Graufelds, V. K., Xu, G., Pearson, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900903106 · Cited by 285
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective
Keov, P., Sexton, P. M., & Christopoulos, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.010 · Cited by 265
Self-citationShirey, J. K., Brady, A. E., Jones, P. J., Davis, A. A., Bridges, T. M., Kennedy, J. P., Jadhav, S. B., Menon, U. N., Xiang, Z., Watson, M. L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3930-09.2009 · Cited by 237
Allosteric modulation of the muscarinic M 4 receptor as an approach to treating schizophrenia
Chan, W. Y., McKinzie, D. L., Bose, S., Mitchell, S. N., Witkin, J. M., Thompson, R. C., Christopoulos, A., Lazareno, S., Birdsall, N. J. M., Bymaster, F. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800567105 · Cited by 235
Self-citationCholinergic Modulation of Cortical Function
Hasselmo, M. E., & Giocomo, L. M. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:133 · Cited by 219
Molecular architecture of G protein-coupled receptors
van Rhee, A. M., & Jacobson, K. A. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199601)37:1<1::aid-ddr1>3.0.co;2-s · Cited by 175
Leach, K., Loiacono, R. E., Felder, C. C., McKinzie, D. L., Mogg, A., Shaw, D. B., Sexton, P. M., & Christopoulos, A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.194 · Cited by 167
Self-citationAvlani, V. A., Gregory, K. J., Morton, C. J., Parker, M. W., Sexton, P. M., & Christopoulos, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702311200 · Cited by 160
Self-citationDirect incorporation of experimental phase information in model refinement
Skubák, P., Murshudov, G. N., & Pannu, N. S. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019079 · Cited by 130
Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis
Thorsen, T. S., Matt, R. A., Weis, W. I., & Kobilka, B. K. (2014) · Structure · doi:10.1016/j.str.2014.08.022 · Cited by 128
Self-citationNawaratne, V., Leach, K., Suratman, N., Loiacono, R. E., Felder, C. C., Armbruster, B. N., Roth, B. L., Sexton, P. M., & Christopoulos, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049353 · Cited by 126
Self-citationScarselli, M., Li, B., Kim, S., & Wess, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610394200 · Cited by 118
Allosteric Modulation of Muscarinic Acetylcholine Receptors
Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2007) · Current Neuropharmacology · doi:10.2174/157015907781695946 · Cited by 115
Self-citationHeinrich, J. N., Butera, J. A., Carrick, T. A., Kramer, A., Kowal, D. M., Lock, T., Marquis, K. L., Pausch, M. H., Popiolek, M., Sun, S.-C., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.044 · Cited by 105
Tautermann, C. S., Kiechle, T., Seeliger, D., Diehl, S., Wex, E., Banholzer, R., Gantner, F., Pieper, M. P., & Casarosa, P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401219y · Cited by 94
Gnagey, A. L., Seidenberg, M., & Ellis, J. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1245 · Cited by 91
Khoury, E., Clément, S., & Laporte, S. A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00068 · Cited by 82
Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.
Noetzel, M. J., Jones, C. K., & Conn, P. J. (2012) · PubMed · Cited by 80
Nawaratne, V., Leach, K., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125096 · Cited by 70
Self-citationAllosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders
Digby, G. J., Shirey-Rice, J. K., & Conn, P. J. (2010) · Molecular BioSystems · doi:10.1039/c002938f · Cited by 69
Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor
Abdul‐Ridha, A., López, L., Keov, P., Thal, D. M., Mistry, S. N., Sexton, P. M., Lane, J. R., Canals, M., & Christopoulos, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.539080 · Cited by 69
Self-citationSuratman, S., Leach, K., Sexton, P. M., Felder, C. C., Loiacono, R. E., & Christopoulos, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01184.x · Cited by 68
Self-citationAbdul‐Ridha, A., Lane, J. R., Mistry, S. N., López, L., Sexton, P. M., Scammells, P. J., Christopoulos, A., & Canals, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.604967 · Cited by 62
Self-citationCroy, C. H., Schober, D. A., Xiao, H., Quets, A. T., Christopoulos, A., & Felder, C. C. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.091751 · Cited by 56
Self-citationMuscarinic acetylcholine receptor X-ray structures: potential implications for drug development
Kruse, A. C., Hu, J., Kobilka, B. K., & Wess, J. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.02.006 · Cited by 47
Self-citationLeach, K., Davey, A. E., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.070938 · Cited by 46
Self-citationGoodwin, J. A., Hulme, E. C., Langmead, C. J., & Tehan, B. G. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038265 · Cited by 42
Cited by
GPCR Dynamics: Structures in Motion
Latorraca, N. R., Venkatakrishnan, A. J., & Dror, R. O. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00177 · Cited by 835
Crystal Structure of the Human Cannabinoid Receptor CB1
Hua, T., Vemuri, K., Pu, M., Qu, L., Han, G. W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.004 · Cited by 673
Crystal Structure of the Human Cannabinoid Receptor CB2
Li, X., Hua, T., Vemuri, K., Ho, J.-H., Wu, Y., Wu, L., Popov, P., Benchama, O., Zvonok, N., Locke, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.011 · Cited by 400
Impact of GPCR Structures on Drug Discovery
Congreve, M., de Graaf, C., Swain, N. A., & Tate, C. G. (2020) · Cell · doi:10.1016/j.cell.2020.03.003 · Cited by 375
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., Ali, M., Li, J., & Li, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23247 · Cited by 351
Metadata
- Authors
- Thal, D. M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C. C., Bures, M. G., Evans, D. A., Weis, W. I., Bachhawat, P., Kobilka, T. S., Sexton, P. M., Kobilka, B. K., & Christopoulos, A.
- Venue
- Nature
- Published
- 2016-03-09
- Volume
- 531
- Issue
- 7594
- Pages
- 335-340
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2295245722
- Cited by
- 335
- References
- 63
- FWCI
- 20.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.